CN105853920A - 一种治疗产后病的中药组合物及其制备方法 - Google Patents
一种治疗产后病的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105853920A CN105853920A CN201610298138.3A CN201610298138A CN105853920A CN 105853920 A CN105853920 A CN 105853920A CN 201610298138 A CN201610298138 A CN 201610298138A CN 105853920 A CN105853920 A CN 105853920A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- medicine composition
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 208000029785 Puerperal disease Diseases 0.000 title claims abstract description 16
- 241000411851 herbal medicine Species 0.000 title abstract 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 241001521474 Liriope <hydrozoan> Species 0.000 claims abstract description 35
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 35
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 35
- 235000008434 ginseng Nutrition 0.000 claims abstract description 35
- 238000000605 extraction Methods 0.000 claims abstract description 14
- 238000009835 boiling Methods 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims description 74
- 239000003814 drug Substances 0.000 claims description 62
- 239000000706 filtrate Substances 0.000 claims description 38
- 235000008504 concentrate Nutrition 0.000 claims description 37
- 239000012141 concentrate Substances 0.000 claims description 37
- 241000208340 Araliaceae Species 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000001914 filtration Methods 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 13
- -1 is dried Substances 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 235000014666 liquid concentrate Nutrition 0.000 claims description 2
- 241000221033 Quisqualis Species 0.000 claims 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 4
- 239000010931 gold Substances 0.000 claims 4
- 229910052737 gold Inorganic materials 0.000 claims 4
- 239000003390 Chinese drug Substances 0.000 claims 1
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 235000001405 Artemisia annua Nutrition 0.000 abstract 1
- 240000000011 Artemisia annua Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000061508 Eriobotrya japonica Species 0.000 abstract 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 abstract 1
- 235000011613 Pinus brutia Nutrition 0.000 abstract 1
- 241000018646 Pinus brutia Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 244000044425 Quisqualis indica Species 0.000 description 25
- 208000024891 symptom Diseases 0.000 description 12
- 238000011084 recovery Methods 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 8
- 230000035807 sensation Effects 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010063659 Aversion Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 210000003128 head Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 5
- 208000007502 anemia Diseases 0.000 description 5
- 235000003826 Artemisia Nutrition 0.000 description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 241000909851 Epiphora Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 244000030166 artemisia Species 0.000 description 3
- 235000009052 artemisia Nutrition 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000021129 Postpartum disease Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010037294 Puerperal pyrexia Diseases 0.000 description 1
- 244000173166 Pyrus ussuriensis Species 0.000 description 1
- 235000011572 Pyrus ussuriensis Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- JHJUUEHSAZXEEO-UHFFFAOYSA-M sodium;4-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 JHJUUEHSAZXEEO-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗产后病的中药组合物及其制备方法,该中药组合物由以下重量份的中药制成:土木香20‑60份、大青叶20‑70份、人参10‑40份、黄芩10‑50份、大枣20‑70份、山楂20‑60份、杜仲10‑40份、山麦冬20‑60份、枇杷叶20‑60份、青蒿15‑60份、松花粉10‑60份、昆布10‑60份、郁金10‑60份、知母10‑60份、使君子15‑65份、甘草10‑40份,通过浸泡、水煮、醇提等工艺制成。治疗产后疾病360例,总有效率达94.4%,效果明显,并且未发现不良反应与毒副作用,说明本发明中药组合物在治疗女性产后疾病疗效显著,具有良好推广价值。
Description
技术领域
本发明涉及医药发明领域,具体涉及一种治疗女性产后病的的中药组合物及其制备方法。
背景技术
产后病,又叫“月子病”,是妇女在生产孩子时期,因筋骨腠理大开,身体虚弱,内外空疏不慎风寒侵入所致,主要表现为产后恶露不尽、子宫复旧不全、产后血亏、血瘀,小腹空坠、疼痛、浑身怕冷、怕风、出虚汗、活动关节疼痛,好着衣,严重的病人夏热天穿棉衣等。这些疾病不仅严重影响产妇的情绪与健康,而且使产妇不能正常哺乳宝宝。对产后疾病做到早预防、早发生、早治疗,对于确保产妇和宝宝的健康都有十分重要的意义。
为了解决上述问题,发明人研发了一种治疗女性产后病的新药。
发明内容
本发明的目的是提供一种治疗产后病的中药组合物。
本发明的另一目的提供一种治疗产后病的中药组合物的制备方法。
本发明提供的治疗产后病的中药组合物由以下重量份的中药制成:土木香20-60份、大青叶20-70份、人参10-40份、黄芩10-50份、大枣20-70份、山楂20-60份、杜仲10-40份、山麦冬20-60份、枇杷叶20-60份、青蒿15-60份、松花粉10-60份、昆布10-60份、郁金10-60份、知母10-60份、使君子15-65份、甘草10-40份。
优选的,本发明所述的中药组合物由以下重量份的中药制成:土木香25-55份、大青叶25-65份、人参12-38份、黄芩15-45份、大枣25-65份、山楂25-55份、杜仲12-38份、山麦冬25-55份、枇杷叶25-55份、青蒿20-55份、松花粉15-55份、昆布15-55份、郁金15-55份、知母15-55份、使君子20-60份、甘草12-38份。
进一步优选的,本发明所述的中药组合物由以下重量份的中药制成:土木香30-50份、大青叶30-60份、人参15-35份、黄芩20-40份、大枣30-60份、山楂30-50份、杜仲15-35份、山麦冬30-50份、枇杷叶30-50份、青蒿30-50份、松花粉20-50份、昆布20-50份、郁金20-50份、知母20-50份、使君子25-55份、甘草15-35份。
更进一步优选的,本发明所述的中药组合物由以下重量份的中药制成:土木香35-45份、大青叶35-55份、人参20-30份、黄芩25-35份、大枣35-55份、山楂35-45份、杜仲20-30份、山麦冬35-45份、枇杷叶35-45份、青蒿35-45份、松花粉25-45份、昆布25-45份、郁金25-45份、知母25-45份、使君子30-50份、甘草20-30份。
更进一步优选的,本发明所述的中药组合物由以下重量份的中药制成:土木香40份、大青叶40份、人参25份、黄芩30份、大枣40份、山楂38份、杜仲25份、山麦冬40份、枇杷叶40份、青蒿40份、松花粉35份、昆布35份、郁金35份、知母35份、使君子40份、甘草25份。
本发明所述的中药组合物还含有药学上可接受的载体或稀释剂。
本发明所述的中药组合物为固体制剂或液体制剂,所述固体制剂为片剂、胶囊剂、颗粒剂或丸剂;所述液体制剂为口服液。
本发明所述的中药组合物的制备方法包括以下步骤:将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶、青蒿、松花粉、昆布、郁金、知母、使君子、甘草粉碎过筛,与药学上可接受的载体或稀释剂混合均匀,制备成制剂。
本发明所述的中药组合物的制备方法包括以下步骤:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入8-15倍量的60%-85%乙醇浸泡11-20天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加10-15倍量的水加热回流提取2-5小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加7-12倍量的水煎煮2-5小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入辅料,制成药学上可接受的剂型。
优选的,本发明所述的中药组合物的制备方法包括以下步骤:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入10倍量的75%乙醇浸泡15天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加12倍量的水加热回流提取3小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加9倍量的水煎煮3小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入辅料,制成药学上可接受的剂型。
所述重量份数可以是μg、mg、g、kg等医药领域公知的重量单位。
倍量的含义是指药材的重量比。
所述药学上可接受的载体或稀释剂是指药学领域常规的药物载体,选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。
其中所述填充剂选自淀粉、蔗糖、乳糖、甘露醇、山梨醇、木糖醇、微晶纤维素或葡萄糖等;
所述粘合剂选自纤维素衍生物、藻酸盐、明胶或聚乙烯吡咯烷酮等;
所述崩解剂选自微晶纤维素、羧甲基淀粉钠、聚乙烯吡咯烷酮、低取代羟丙基纤维素或交联羧甲基纤维素钠;
所述润滑剂选自硬脂酸、聚乙二醇、碳酸钙、碳酸氢钠、二氧化硅、滑石粉或硬脂酸镁;
所述表面活性剂选自十二烷基苯磺酸钠、硬脂酸、聚氧乙烯-聚氧丙烯共聚物、脂肪酸山梨坦或聚山梨酯(吐温)等;
所述矫味剂选自阿斯巴甜、蔗糖素或糖精钠。
本发明提供的中药组合物具有以下优点:
本发明在治疗女性产后病如:贫血、产后恶露逾期不止、小腹空坠、眼睛遇风流泪、浑身怕冷、怕风、出虚汗、活动关节疼痛等方面有良好的效果,治疗产后疾病360例,总有效率达94.4%,效果明显,并且未发现不良反应与毒副作用,说明本发明中药组合物在治疗女性产后疾病疗效显著,具有良好推广价值。
具体实施方式
以下实施例用于说明本发明,但不用来限制本发明的范围。
实施例1
组方:土木香20g、大青叶20g、人参10g、黄芩10g、大枣20g、山楂20g、杜仲10g、山麦冬20g、枇杷叶20g、青蒿15g、松花粉10g、昆布10g、郁金10g、知母10g、使君子15g、甘草10g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入8倍量的60%乙醇浸泡11天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加10倍量的水加热回流提取2小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加7倍量的水煎煮2-5小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入占混合均匀细粉重量2/5的淀粉,装入胶囊,制成胶囊剂。
实施例2
组方:土木香60g、大青叶70g、人参40g、黄芩50g、大枣70g、山楂60g、杜仲40g、山麦冬60g、枇杷叶60g、青蒿60g、松花粉60g、昆布60g、郁金60g、知母60g、使君子65g、甘草40g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入15倍量的85%乙醇浸泡20天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加15倍量的水加热回流提取5小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加12倍量的水煎煮5小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入占混合均匀细粉重量2/5的淀粉,装入胶囊,制成胶囊剂。
实施例3
组方:土木香25g、大青叶25g、人参12g、黄芩15g、大枣25g、山楂25g、杜仲12g、山麦冬25g、枇杷叶25g、青蒿20g、松花粉15g、昆布15g、郁金15g、知母15g、使君子20g、甘草12g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入11倍量的75%乙醇浸泡15天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加10-15倍量的水加热回流提取3小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加9倍量的水煎煮2-5小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入占混合均匀细粉重量1/5的淀粉,干燥,压片,即得本申请的片剂。
实施例4
组方:土木香55g、大青叶65g、人参38g、黄芩45g、大枣65g、山楂55g、杜仲38g、山麦冬55g、枇杷叶55g、青蒿55g、松花粉55g、昆布55g、郁金55g、知母55g、使君子60g、甘草38g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入13倍量的75%乙醇浸泡16天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加12倍量的水加热回流提取4小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加9倍量的水煎煮2-5小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入占混合均匀细粉重量1/5的淀粉,混匀,制粒,干燥,整粒,得到本申请的颗粒剂。
实施例5
组方:土木香25g、大青叶25g、人参12g、黄芩15g、大枣25g、山楂25g、杜仲12g、山麦冬25g、枇杷叶25g、青蒿20g、松花粉15g、昆布15g、郁金15g、知母15g、使君子20g、甘草12g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入10倍量的75%乙醇浸泡16天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加13倍量的水加热回流提取4小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加8倍量的水煎煮2-5小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入5倍量灭菌水,过滤,加入占滤液1/8的阿斯巴甜,灌注,压盖,灭菌,得到本申请的口服液。
实施例6
组方:土木香55g、大青叶65g、人参38g、黄芩45g、大枣65g、山楂55g、杜仲38g、山麦冬55g、枇杷叶55g、青蒿55g、松花粉55g、昆布55g、郁金55g、知母55g、使君子60g、甘草38g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入14倍量的80%乙醇浸泡14天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加13倍量的水加热回流提取4小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加10倍量的水煎煮2-5小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入占混合均匀细粉重量1/11的糊精,混匀,制丸,干燥,得到本申请的微丸。
实施例7
组方:土木香35g、大青叶35g、人参20g、黄芩25g、大枣35g、山楂35g、杜仲20g、山麦冬35g、枇杷叶35g、青蒿35g、松花粉25g、昆布25g、郁金25g、知母25g、使君子30g、甘草20g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入10倍量的75%乙醇浸泡15天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加12倍量的水加热回流提取3小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加9倍量的水煎煮3小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入占混合均匀细粉重量2/5的淀粉,装入胶囊,制成胶囊剂。
实施例8
组方:土木香45g、大青叶55g、人参30g、黄芩35g、大枣55g、山楂45g、杜仲30g、山麦冬45g、枇杷叶45g、青蒿45g、松花粉45g、昆布45g、郁金45g、知母45g、使君子50g、甘草30g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入10倍量的75%乙醇浸泡15天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加12倍量的水加热回流提取3小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加9倍量的水煎煮3小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入占混合均匀细粉重量2/5的淀粉,装入胶囊,制成胶囊剂。
实施例9
组方:土木香40g、大青叶40g、人参25g、黄芩30g、大枣40g、山楂38g、杜仲25g、山麦冬40g、枇杷叶40g、青蒿40g、松花粉35g、昆布35g、郁金35g、知母35g、使君子40g、甘草25g。
制备方法:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入10倍量的75%乙醇浸泡15天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加12倍量的水加热回流提取3小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加9倍量的水煎煮3小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入占混合均匀细粉重量2/5的淀粉,装入胶囊,制成胶囊剂。
为了进一步简述本发明的有益效果,发明人做了临床试验。
临床资料
1、病例来源
在志愿者中随机选取360名产后患者进行实验,年龄在23-37岁之间,平均年龄26岁,患者临床症状为:贫血、产后恶露逾期不止、小腹空坠、眼睛遇风流泪、浑身怕冷、怕风、出虚汗,活动关节疼痛。
2、治疗方法
将上述患者平均分为9组,各组之间无显著性差异,将这9组患者分别服用本发明实施例1-9的药物,每天3次,连续服用4周。
3、疗效标准
疗效评定标准:疗效评定标准参照《中医药新药临床研究指导原则》制定:治愈:临床症状体征消失;
显效:临床症状体征基本或大部分消失;
有效:临床症状体征有减轻或缓解;
无效:临床症状体征无改善。
4、实验结果
绝大部分患者在按照本发明方法使用药物7天左右会有症状明显减轻的感觉,服用4周后,产后贫血、恶露逾期不止、小腹空坠、疼痛、浑身怕冷、怕风、出虚汗,活动关节疼痛症状消失或痊愈。
根据统计,360例患者在使用本发明药物4周后的效果见表1:
表1疗效统计表
| 组别 | 服用剂量 | 临床痊愈 | 显效 | 有效 | 无效 | 合计 | 有效率(%) |
| 实施例1 | 4g/次 | 25 | 10 | 4 | 1 | 40 | 97.5% |
| 实施例2 | 4g/次 | 22 | 8 | 7 | 3 | 40 | 92.5% |
| 实施例3 | 4g/次 | 24 | 11 | 4 | 1 | 40 | 97.5% |
| 实施例4 | 4g/次 | 18 | 8 | 12 | 2 | 40 | 95.0% |
| 实施例5 | 5ml/次 | 19 | 9 | 11 | 1 | 40 | 97.5% |
| 实施例6 | 4g/次 | 18 | 8 | 11 | 3 | 40 | 92.5% |
| 实施例7 | 4g/次 | 20 | 9 | 8 | 3 | 40 | 92.5% |
| 实施例8 | 4g/次 | 21 | 9 | 8 | 2 | 40 | 95.0% |
| 实施例9 | 4g/次 | 22 | 9 | 5 | 4 | 40 | 90.0% |
治疗产后疾病360例,总有效率达94.4%,效果明显,并且未发现不良反应与毒副作用,说明本发明中药组合物在治疗女性产后疾病疗效显著,具有良好推广价值。
典型病例:
病例1:李某,25岁,2个月前顺产一女婴,产后小腹空坠、疼痛、活动关节疼痛,服用本发明实施例1,3周后症状大减,继续服用10天,痊愈。
病例2:韩某,26岁,3个月前剖腹产下一男婴,产后畏寒、腰腿酸疼、眼睛迎风流泪,服用本发明的实施例2,20天后症状消失。
病例3:李某,30岁,5个月前顺产一男婴,出院后,怕风、出虚汗、畏寒,腰腿酸疼,免疫力低下,易感冒头疼,服用本发明的实施例3,15天后,症状消失,痊愈。
病例4:李某,28岁,3个月前剖腹产下一女婴,浑身怕冷、怕风、出虚汗,活动关节疼痛。服用本发明实施例4,2周后,痊愈。
病例5:韩某,23岁,4个月前剖腹产一男婴,出院后,小腹空坠、疼痛、浑身怕冷、活动关节疼痛。服用本发明实施例5,2周后症状大减,继续服用10天,痊愈。
病例6:黄某,24岁,3个月前剖腹产一女婴。出院后,头痛、畏寒、腰腿酸疼、眼睛迎风流泪。服用本发明实施例6,1周后症状大减,继续服用10天,痊愈。
病例7:关某,28岁,5个月前剖腹产一女婴,出院后,贫血、头痛、畏寒、腰腿酸疼、眼睛迎风流泪。服用本发明实施例7,2周后症状大减,继续服用5天,痊愈。
病例8:李某,29岁,3个月前顺产一女婴,出院后,怕风、出虚汗、畏寒,腰腿酸疼,免疫力低下,服用本发明的实施例8,30天后症状消失,免疫力增强,痊愈。
病例9:杜某,女,32岁,3个月前剖腹产一女婴,出院后,体质虚弱,面白汗出,小腹空坠、疼痛、浑身怕冷。服用本发明实施例9,1周后症状大减,继续服用5天,痊愈。
虽然,上文中已经用一般性说明、具体实施方式及试验,对本发明作了详尽的描述,但在本发明基础上,可以对之作出一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (10)
1.一种治疗产后病的中药组合物,其特征在于,该中药组合物由以下重量份的中药制成:土木香20-60份、大青叶20-70份、人参10-40份、黄芩10-50份、大枣20-70份、山楂20-60份、杜仲10-40份、山麦冬20-60份、枇杷叶20-60份、青蒿15-60份、松花粉10-60份、昆布10-60份、郁金10-60份、知母10-60份、使君子15-65份、甘草10-40份。
2.根据权利要求1所述的中药组合物,其特征在于,该中药组合物由以下重量份的中药制成:土木香25-55份、大青叶25-65份、人参12-38份、黄芩15-45份、大枣25-65份、山楂25-55份、杜仲12-38份、山麦冬25-55份、枇杷叶25-55份、青蒿20-55份、松花粉15-55份、昆布15-55份、郁金15-55份、知母15-55份、使君子20-60份、甘草12-38份。
3.根据权利要求2所述的中药组合物,其特征在于,该中药组合物由以下重量份的中药制成:土木香30-50份、大青叶30-60份、人参15-35份、黄芩20-40份、大枣30-60份、山楂30-50份、杜仲15-35份、山麦冬30-50份、枇杷叶30-50份、青蒿30-50份、松花粉20-50份、昆布20-50份、郁金20-50份、知母20-50份、使君子25-55份、甘草15-35份。
4.根据权利要求3所述的中药组合物,其特征在于,该中药组合物由以下重量份的中药制成:土木香35-45份、大青叶35-55份、人参20-30份、黄芩25-35份、大枣35-55份、山楂35-45份、杜仲20-30份、山麦冬35-45份、枇杷叶35-45份、青蒿35-45份、松花粉25-45份、昆布25-45份、郁金25-45份、知母25-45份、使君子30-50份、甘草20-30份。
5.根据权利要求4所述的中药组合物,其特征在于,该中药组合物由以下重量份的中药制成:土木香40份、大青叶40份、人参25份、黄芩30份、大枣40份、山楂38份、杜仲25份、山麦冬40份、枇杷叶40份、青蒿40份、松花粉35份、昆布35份、郁金35份、知母35份、使君子40份、甘草25份。
6.根据权利要求1-5任一项所述的中药组合物,其特征在于,该中药组合物还含有药学上可接受的载体或稀释剂。
7.根据权利要求6所述的中药组合物,其特征在于,所述中药组合物为固体制剂或液体制剂,所述固体制剂为片剂、胶囊剂、颗粒剂或丸剂;所述液体制剂为口服液。
8.一种制备权利要求1-5任一项所述的中药组合物的制备方法,其特征在于,该方法包括以下步骤:将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶、青蒿、松花粉、昆布、郁金、知母、使君子、甘草粉碎过筛,与药学上可接受的载体或稀释剂混合均匀,制备成制剂。
9.一种制备权利要求1-5任一项所述的中药组合物的制备方法,其特征在于,该方法包括以下步骤:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入8-15倍量的60%-85%乙醇浸泡11-20天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加10-15倍量的水加热回流提取2-5小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加7-12倍量的水煎煮2-5小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入辅料,制成药学上可接受的剂型。
10.根据权利要求9所述的中药组合物的制备方法,其特征在于,该方法包括以下步骤:
1)分别称取重量份的中药,备用;
2)将土木香、大青叶、人参、黄芩、大枣、山楂、杜仲、山麦冬、枇杷叶加入10倍量的75%乙醇浸泡15天,过滤,滤液浓缩、干燥,粉碎成细粉,备用;滤渣加12倍量的水加热回流提取3小时,过滤,滤液浓缩,干燥,粉碎成细粉,备用;
3)将青蒿、松花粉、昆布、郁金、知母、使君子、甘草加9倍量的水煎煮3小时,过滤,滤液浓缩、干燥,粉碎成细粉,备用;
4)将步骤2)3)备用的细粉混合均匀,加入辅料,制成药学上可接受的剂型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610298138.3A CN105853920A (zh) | 2016-04-25 | 2016-04-25 | 一种治疗产后病的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610298138.3A CN105853920A (zh) | 2016-04-25 | 2016-04-25 | 一种治疗产后病的中药组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105853920A true CN105853920A (zh) | 2016-08-17 |
Family
ID=56630541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610298138.3A Pending CN105853920A (zh) | 2016-04-25 | 2016-04-25 | 一种治疗产后病的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105853920A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107050199A (zh) * | 2016-11-10 | 2017-08-18 | 刁媛媛 | 一种治疗女性产后病的药物组合物 |
| CN107050235A (zh) * | 2016-11-10 | 2017-08-18 | 刁媛媛 | 一种治疗产后血虚气脱的药物组合物 |
| CN109350663A (zh) * | 2018-09-20 | 2019-02-19 | 于雪梅 | 一种治疗产褥感染的药物组合物及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150023A (zh) * | 1995-11-07 | 1997-05-21 | 罗苓 | 一种治疗妇女产后病的中药 |
| CN1245697A (zh) * | 1998-08-20 | 2000-03-01 | 陈凤庭 | 治疗妇女产后病的中药胶囊 |
| CN1513484A (zh) * | 2002-12-31 | 2004-07-21 | 魏文利 | 一种用于治疗妇女产后病的中药 |
| CN102319393A (zh) * | 2011-08-01 | 2012-01-18 | 陕西步长制药有限公司 | 一种药物组合物在制备治疗产后病药物中的应用 |
| CN102784311A (zh) * | 2012-08-28 | 2012-11-21 | 李山岭 | 一种治疗妇女产后病的中药组合物及其制备方法 |
-
2016
- 2016-04-25 CN CN201610298138.3A patent/CN105853920A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150023A (zh) * | 1995-11-07 | 1997-05-21 | 罗苓 | 一种治疗妇女产后病的中药 |
| CN1245697A (zh) * | 1998-08-20 | 2000-03-01 | 陈凤庭 | 治疗妇女产后病的中药胶囊 |
| CN1513484A (zh) * | 2002-12-31 | 2004-07-21 | 魏文利 | 一种用于治疗妇女产后病的中药 |
| CN102319393A (zh) * | 2011-08-01 | 2012-01-18 | 陕西步长制药有限公司 | 一种药物组合物在制备治疗产后病药物中的应用 |
| CN102784311A (zh) * | 2012-08-28 | 2012-11-21 | 李山岭 | 一种治疗妇女产后病的中药组合物及其制备方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107050199A (zh) * | 2016-11-10 | 2017-08-18 | 刁媛媛 | 一种治疗女性产后病的药物组合物 |
| CN107050235A (zh) * | 2016-11-10 | 2017-08-18 | 刁媛媛 | 一种治疗产后血虚气脱的药物组合物 |
| CN109350663A (zh) * | 2018-09-20 | 2019-02-19 | 于雪梅 | 一种治疗产褥感染的药物组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102309716A (zh) | 一种治疗带下症的中药组合物及其制备方法 | |
| CN102512644B (zh) | 一种祛斑养颜的中药组合物及其制备方法 | |
| CN105853920A (zh) | 一种治疗产后病的中药组合物及其制备方法 | |
| CN104208220A (zh) | 一种用于治疗舒缓痔疮的中药制剂 | |
| CN102512649A (zh) | 一种治疗产后瘀血的中药组合物及其制备方法 | |
| CN105709077A (zh) | 一种治疗产后病的中药组合物及其制备方法 | |
| CN102670824A (zh) | 一种内服治疗冠心病的中药制剂 | |
| CN105521332A (zh) | 治疗肛裂的中药组合物及其制备方法和应用 | |
| CN107773695A (zh) | 一种用于治疗扁平疣的中药 | |
| CN105213887A (zh) | 一种用于治疗青光眼的中药组合物 | |
| CN105833043A (zh) | 一种中药组合物在制备治疗原发性高血压药物中的用途 | |
| CN118252889B (zh) | 一种治疗蛇串疮的药物及其制备方法 | |
| CN105148147A (zh) | 治疗创伤或褥疮感染的中药及其制备方法 | |
| CN104258113B (zh) | 一种治疗脑出血的中药组合物 | |
| CN102813875B (zh) | 一种治疗红斑狼疮的中药组合物及其应用 | |
| CN110841007B (zh) | 一种治疗脑中风后遗症的中药组合物及其应用 | |
| CN105535658A (zh) | 一种治疗口腔溃疡的中药组合物及其制备方法 | |
| CN105663577A (zh) | 一种产后护理的中药组合物及其制备方法 | |
| CN106177590A (zh) | 一种用于治疗小儿抽动秽语综合征的中药胶囊 | |
| CN105770828A (zh) | 一种治疗内分泌失调的中药组合物及其制备方法 | |
| CN104873572A (zh) | 一种治疗产后少乳的中药组合物及其制备方法 | |
| CN104524474A (zh) | 治疗胆道结石的中药组合物及制法 | |
| CN104940561A (zh) | 一种治疗眼疾的中药制剂及其制备方法 | |
| CN105233035A (zh) | 治疗耳聋的中药制剂及制法 | |
| CN103948783A (zh) | 一种预防和/或治疗脑梗塞的药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160817 |
|
| WD01 | Invention patent application deemed withdrawn after publication |